Probiotics May Save Lives of Premature Babies, Study Finds

Study Shows Probiotics Can Reduce Severe NEC Cases

As a Senior Business Correspondent who has covered health policy and medical innovation, I've seen how small shifts in clinical practice can have profound impacts on patient outcomes. A new study published in JAMA Network Open provides compelling evidence that probiotics may play a crucial role in improving survival rates for premature babies. This is not just another research paper—it's a potential turning point in neonatal care.

Sweden's Approach to Neonatal Care

The study, led by researchers at Karolinska Institutet in Sweden, analyzed data from over 4,600 very preterm infants born between 28 and 31 weeks' gestation. What stood out was the dramatic reduction in severe necrotizing enterocolitis (NEC) cases—particularly those requiring surgery—among babies who received probiotics.

"What was more striking was the magnitude of the association, particularly for the most severe forms of NEC requiring surgery," said Ayoub Mitha, MD, PhD, the study's corresponding author.

The results were striking: only one case of surgical NEC occurred among 1,571 infants who received probiotics, compared to 40 cases in 3,124 infants who did not. That translates to a 97% reduction in severe NEC cases requiring surgical intervention.

The Science Behind Probiotics and Gut Health

NEC is a serious condition that causes inflammation and can lead to death in premature babies. The gut microbiome plays a critical role in the development of healthy digestive systems, especially in preterm infants who are more susceptible to infections and complications.

Probiotics introduce beneficial bacteria into the gut that help maintain a balanced microbial environment. This balance is essential for proper digestion and immune system function—both crucial factors for preterm babies who often struggle with these issues due to underdeveloped organs and immune systems.

A Look at the Data

The researchers compared outcomes before and after probiotics were introduced nationally across Swedish neonatal intensive care units (NICUs). The study included a large cohort of infants, making it one of the most robust analyses of its kind to date.

Thao (Tina) Ho, associate professor and chief of neonatology at the University of South Florida Morsani College of Medicine, praised the study's methodological rigor. "The large sample size and consistent use of a well-characterized probiotic formulation are strengths," she noted.

However, Ho also cautioned that because this was an observational study, it cannot definitively prove causation. Other factors—such as improved nutrition protocols or better infection control practices—could have contributed to the improved outcomes over time.

Clinical Implications and Future Research

The implications for clinical practice are significant. If these findings are replicated in other settings, probiotics could become a standard part of care for preterm infants, potentially saving lives and reducing long-term complications.

Mitha highlighted the importance of future research focusing on extremely preterm infants born before 28 weeks, who face the greatest risks but were not included in this study. He mentioned that work is currently underway in the PEPS trial—a large placebo-controlled randomized trial being conducted in Sweden and Denmark.

What Parents Need to Know

While these results are promising, they should not be interpreted as a recommendation for parents to use probiotics at home. Store-bought probiotics are not regulated or tested specifically for preterm infants and could pose risks. As always, any decision about treatment should be made in consultation with a medical team.

"If they do offer probiotics, you should discuss with your baby's medical team about the risks and benefits so that you can make the decision together," advised Ho.

The Bigger Picture

This study is part of a broader trend in neonatal medicine where personalized treatments are becoming more common. The growing understanding of how gut microbiomes affect overall health has opened new doors for preventive care—not just for premature babies, but for people across the lifespan.

As we continue to see breakthroughs in this field, one thing remains clear: when it comes to healthcare innovations that save lives, even small changes can make a world of difference.

The results from this Swedish study offer hope—not just for the families affected by preterm birth, but for medical professionals working tirelessly to improve outcomes in NICUs around the globe.